The Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, ANVISA) has approved Morinaga’s probiotic strain Bifidobacterium longum subsp. longum BB536 for us in dietary supplements and conventional food products sold in Brazil.
The strain, which is the newest addition to the company’s human health probiotics portfolio, achieved a “clinically meaningful response” for improving gut health for people with adults with IBS-D.
Dramatic environmental changes during the early COVID-19 pandemic have disrupted the development and diversity of the infant gut microbiome, according to data collected from infants living in New York City.
Responses to probiotic interventions can vary between people, but a new study suggesting that an initial metabologenomic analysis of the gut microbiota may remove the guess work and allow for accurate predictions of the potential effects of a probiotic.
Daily supplementation with 600 mg of an elderberry extract may boost diversity of the gut microbiota, with specific increases in levels of Akkermansia, says a new study from Austria and Italy.
Daily consumption of three probiotic strains may led to changes in connectivity between various regions of the brain and exert subtle improvements on psychological health, says a new study using a GSK product.
Next generation Bifidobacteria probiotics developed using CRISPR gene editing technology are one step closer after a new paper showed how select techniques could be applied in a programmable and strain-dependent manner.
Food, beverage and dietary supplement company DuPont Nutrition & Biosciences (N&B), and leader in the role of microbes, APC Microbiome, are uniting to develop microbiome-based solutions in infant health.
A new paper by Brazilian researchers elucidates ways in which polyphenols may help shift the gut microbiome away from states associated with obesity and metabolic disorders.
